UiPath Inc. PATH | NYSE

$12.77 -$0.04 | -0.27%

Company Overview:

Market Cap: $6.83B
PE Ratio: -106.38
52-Week Range: $9.38 - $15.93

4.2 Year PATH Performance Metrics:

Total Return (with DRIP): -81.4% (-33.03% CAGR)
Total Return (no DRIP): -81.4% (-33.03% CAGR)
Share Price: -81.4% (-33.03% CAGR)
PATH Total Return
1Y 2Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$35/mo
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 20% OFF
$336/yr
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

PATH Earnings, Revenue, Cash & Debt, Shares Outstaning:

PATH - Revenue
7-Day FREE Trial Get Full Access Now!
PATH Revenue CAGR:1Y: 6.42%2Y: 10.97%5Y: 25.82%10Y: 0.00%
PATH - Earnings Per Share (EPS)
7-Day FREE Trial Get Full Access Now!
PATH EPS CAGR:1Y: -18.45%2Y: -15.23%5Y: -17.87%10Y: 0.00%
PATH - Net Income
7-Day FREE Trial Get Full Access Now!
PATH Net Income CAGR:1Y: -21.51%2Y: -15.91%5Y: -15.66%10Y: 0.00%
PATH - EBITDA
7-Day FREE Trial Get Full Access Now!
PATH EBITDA CAGR:1Y: -70.47%2Y: -40.94%5Y: -20.61%10Y: 0.00%
PATH - Free Cash Flow
7-Day FREE Trial Get Full Access Now!
PATH Free Cash Flow CAGR:1Y: 7.46%2Y: 27.34%5Y: 44.58%10Y: 0.00%
PATH - Free Cash Flow / Share
7-Day FREE Trial Get Full Access Now!
PATH Free Cash Flow / Share CAGR:1Y: 11.67%2Y: 28.43%5Y: 42.49%10Y: 0.00%
PATH - Operating Income
7-Day FREE Trial Get Full Access Now!
PATH Operating Income CAGR:1Y: -66.82%2Y: -40.53%5Y: -18.22%10Y: 0.00%
PATH - Gross Profit
7-Day FREE Trial Get Full Access Now!
PATH Gross Profit CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: 0.00%
PATH - Shares Outstanding
7-Day FREE Trial Get Full Access Now!
PATH Shares Outstanding CAGR:1Y: -3.77%2Y: -0.85%5Y: 2.19%10Y: 0.00%
PATH - Share Buybacks
7-Day FREE Trial Get Full Access Now!
PATH Share Buybacks CAGR:1Y: 933.97%2Y: 196.38%5Y: 0.00%10Y: 0.00%
PATH - Stock-Based Comp
7-Day FREE Trial Get Full Access Now!
PATH Stock-Based Comp CAGR:1Y: -13.94%2Y: -5.24%5Y: 56.24%10Y: 0.00%
PATH - Expenses
7-Day FREE Trial Get Full Access Now!
PATH Expenses CAGR:1Y: 936.51%2Y: 161.95%5Y: 94.58%10Y: 0.00%
PATH - Revenue vs Net Income
7-Day FREE Trial Get Full Access Now!
PATH - EPS vs FCF / Share
7-Day FREE Trial Get Full Access Now!
PATH - EPS vs PE Ratio
7-Day FREE Trial Get Full Access Now!
PATH - FCF vs FCF / Share
7-Day FREE Trial Get Full Access Now!
PATH - FCF vs Stock Based Comp
7-Day FREE Trial Get Full Access Now!
PATH - Cash & Debt
7-Day FREE Trial Get Full Access Now!
PATH - Revenue by Segment
7-Day FREE Trial Get Full Access Now!
PATH Revenue CAGR:1Y: 6.42%2Y: 10.97%5Y: 25.82%10Y: 0.00%
PATH - Revenue by Region
7-Day FREE Trial Get Full Access Now!
PATH Revenue CAGR:1Y: 6.42%2Y: 10.97%5Y: 25.82%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

PATH - REVENUE: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
PATH Actual Revenue CAGR:1Y: 6.42%2Y: 10.97%5Y: 25.82%10Y: 0.00%
PATH - EPS: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
PATH Actual EPS CAGR:1Y: -18.45%2Y: -15.23%5Y: -17.87%10Y: 0.00%
PATH - NET INCOME: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
PATH Actual Net Income CAGR:1Y: -21.51%2Y: -15.91%5Y: -15.66%10Y: 0.00%
PATH - EBITDA: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
PATH Actual EBITDA CAGR:1Y: -70.47%2Y: -40.94%5Y: -20.61%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

PATH - Net Profit Margin
7-Day FREE Trial Get Full Access Now!
PATH Net Profit Margin CAGR:1Y: -26.34%2Y: -24.27%5Y: -32.97%10Y: 0.00%
PATH - Gross Profit Margin
7-Day FREE Trial Get Full Access Now!
PATH Gross Profit Margin CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: 0.00%
PATH - Price to Earnings
7-Day FREE Trial Get Full Access Now!
PATH - Price To Sales Ratio
7-Day FREE Trial Get Full Access Now!
PATH - Return on Capital Employed
7-Day FREE Trial Get Full Access Now!
PATH - Return on Invested Capital
7-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

Projected Future Returns & Dividends for PATH

Based on past 4.2-year performance, here are PATH growth metrics:

Share price CAGR of -33.03%
Dividend CAGR of +0%

Using PATH CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

PATH (DRIP)PATH - No DRIP
Current Price$12.81$12.81
Start Shares780.64780.64
Start Value$10,000$10,000
  
After 10 years:
Final Share Count780.64780.64
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$0.35$12.81
Total Dividends$0$0
Final Value$271$10,000

Estimated Future Value + Dividends - PATH

NOTE: Above numbers are our estimate based on PATH's Dividend and Price CAGR over past 4.2 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$35/mo
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 20% OFF
$336/yr
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

UiPath Inc. (PATH) had its IPO on 2021-04-21, and is trader on NYSE stock exchange.

UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform combines artificial intelligence with desktop recording, back-end mining of both human activity and system logs, and intuitive visualization tools, which enables users to discover, analyze, and identify processes to automate in a centralized portal; offers low-code development environments that allows users in an organization to create attended and unattended automations without any prior knowledge of coding; deploys robots in highly immersive attended experiences or in standalone, unattended modes behind the scenes, and can leverage native connectors built for commonly used line-of-business applications; offers centralized tools designed to manage, test, and deploy automations and ML models across the enterprise; allows customers to manage long running processes that orchestrate work between robots and humans; and enable users to track, measure, and forecast the performance of automation in their enterprise and help businesses ensure compliance with business standards. In addition, the company provides maintenance and support for its software, as well as professional services, such as training and implementation services to facilitate the adoption of its platform. It serves banking, healthcare, financial services, and government entities. UiPath Inc. was founded in 2005 and is headquartered in New York, New York.

PATH website: https://www.uipath.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$35/mo
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 20% OFF
$336/yr
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial